children vaccine: Covovax for 7-12-year-olds: Panel seeks more data

India’s Expert Committee on COVID-19 Vaccines has consulted Serum Institute of India (Serum Institute of India) to review its application to allow use of its Kovovax vaccine in the age group of 7-12 years, amid rising coronavirus infection among school children, people. SII) asked for more data. Said in the address.

SII presented interim safety and immunosuppression data over a two-month period after a second dose of Kovovax was administered to 225 participants aged 7-12 years.

DCGI’s Subject Expert Committee, which reviewed the data last week, has sought additional information from the company. “The application will be taken up for evaluation once again after the company submits the data asked from them,” said one of the persons quoted earlier. Kovovax received emergency use authorization in March in the 12-17 year age group. However, it is still not included in the country’s vaccination campaign.

Originally published at Pen 18